Published in Mol Pharmacol on November 01, 1997
Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors. Proc Natl Acad Sci U S A (2000) 1.75
Influence of nonsteroidal anti-inflammatory drugs on aspirin's antiplatelet effects and suggestion of the most suitable time for administration of both agents without resulting in interaction. J Pharm Health Care Sci (2017) 1.39
The 2'-Trifluoromethyl Analogue of Indomethacin Is a Potent and Selective COX-2 Inhibitor. ACS Med Chem Lett (2013) 0.99
Immunomodulatory drug CC-4047 is a cell-type and stimulus-selective transcriptional inhibitor of cyclooxygenase 2. J Clin Immunol (2007) 0.97
Zymosan-induced glycerylprostaglandin and prostaglandin synthesis in resident peritoneal macrophages: roles of cyclo-oxygenase-1 and -2. Biochem J (2006) 0.97
The structure of NS-398 bound to cyclooxygenase-2. J Struct Biol (2011) 0.91
Comparative residue interaction analysis (CoRIA): a 3D-QSAR approach to explore the binding contributions of active site residues with ligands. J Comput Aided Mol Des (2006) 0.85
Automated docking and molecular dynamics simulations of nimesulide in the cyclooxygenase active site of human prostaglandin-endoperoxide synthase-2 (COX-2). J Comput Aided Mol Des (2000) 0.78
Docking studies on NSAID/COX-2 isozyme complexes using contact statistics analysis. J Comput Aided Mol Des (2004) 0.78
Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs. J Comput Aided Mol Des (2002) 0.77
Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study. J Mol Model (2010) 0.77
Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit. J Biol Chem (2016) 0.75
Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med (1998) 5.59
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
Dissociation of vesicular stomatitis virus and relation of the virion proteins to the viral transcriptase. J Virol (1972) 3.84
Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature (1999) 3.57
Properties of the product synthesized by vesicular stomatitis virus particles. J Mol Biol (1971) 3.55
Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study. Indian J Ophthalmol (2001) 2.96
Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem (2000) 2.89
Kinetics of RNA synthesis by vesicular stomatitis virus particles. J Mol Biol (1971) 2.86
Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res (1995) 2.74
Genome homology of vesicular stomatitis virus and defective T particles and evidence for the sequential transcription of the virion ribonucleic acid. J Virol (1972) 2.70
Crystal structure of SIV matrix antigen and implications for virus assembly. Nature (1995) 2.59
Abdominal tuberculosis. Diagnosis by fine needle aspiration cytology. Acta Cytol (1993) 2.26
Identification and isolation of a membrane protein necessary for leukotriene production. Nature (1990) 2.20
Late messenger RNA production by viable simian virus 40 mutants with deletions in the leader region. J Mol Biol (1981) 2.18
Complete sequence of bluetongue virus L2 RNA that codes for the antigen recognized by neutralizing antibodies. J Virol (1985) 2.17
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol (2003) 2.16
The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol (1990) 2.11
Discovery of a receptor related to the galanin receptors. FEBS Lett (1999) 2.01
Initiation and direction of RNA transcription by vesicular stomatitis virus virion transcriptase. J Virol (1973) 1.95
Detection of homologous RNA sequences among six rhabdovirus genomes. J Virol (1974) 1.91
Isolation and properties of poliovirus minus strand ribonucleic acid. J Virol (1970) 1.88
Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV. J Virol (1990) 1.78
Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J (2000) 1.73
Unspliced functional late 19S mRNAs containing intervening sequences are produced by a late leader mutant of simian virus 40. Proc Natl Acad Sci U S A (1981) 1.71
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther (2001) 1.65
Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor. Biotechnol Bioeng (2001) 1.64
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther (1999) 1.63
The crystal structure of bluetongue virus VP7. Nature (1995) 1.61
An improved CAT assay for promoter analysis in either transgenic mice or tissue culture cells. DNA Cell Biol (1992) 1.59
Behaviour of Chrysomya megacephala (Fabr.) and Hemipyrellia ligurriens (Wied.) as parasites of living animals under experimental conditions. S Afr J Med Sci (1971) 1.59
Complete sequence of the NS1 gene (M6 RNA) of US bluetongue virus serotype 10. Nucleic Acids Res (1987) 1.59
Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. J Biol Chem (1990) 1.54
Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain (1987) 1.54
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530. Bioorg Med Chem Lett (1998) 1.54
Burns management and junior staff--what do they know? Burns Incl Therm Inj (1989) 1.52
Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol Pharmacol (1994) 1.49
Schizophyllum commune as an emerging fungal pathogen: a review and report of two cases. Mycoses (2012) 1.48
Nucleoside triphosphate phosphotransferase. A new enzyme activity of oncogenic and non-oncogenic "budding" viruses. Biochim Biophys Acta (1971) 1.47
Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins. J Virol (1990) 1.46
Spectrum of echocardiographic findings in bacterial endocarditis. Circulation (1976) 1.44
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol (1997) 1.44
Tagging sentinel lymph nodes: a study of 100 patients with breast cancer. Eur J Cancer (1999) 1.44
Molecular basis of bluetongue virus neutralization. J Virol (1983) 1.41
Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A. Virology (1993) 1.39
Transiently decreased sialylation of thyrotropin (TSH) in a patient with the euthyroid sick syndrome. Thyroid (1997) 1.39
Contralateral relapse after surgery for breast cancer: evaluation of follow-up paradigms. Int J Clin Pract (2013) 1.39
Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br J Cancer (2007) 1.39
Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med (2001) 1.37
Complete nucleotide sequence of the group-reactive antigen VP7 gene of bluetongue virus. Nucleic Acids Res (1988) 1.37
Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood (1998) 1.36
A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry (1987) 1.35
Three-dimensional structure of single-shelled bluetongue virus. J Virol (1992) 1.35
Nucleotide sequence of a cDNA clone of RNA segment 10 of bluetongue virus (serotype 10). J Gen Virol (1986) 1.34
Cloning of the bluetongue virus L3 gene. J Virol (1984) 1.33
Transcription of the influenza ribonucleic acid genome by a virion polymerase. 3. Completeness of the transcription process. J Virol (1972) 1.33
Signatures of the hydrogen bonding in the infrared bands of water. J Chem Phys (2005) 1.30
The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor. Bioorg Med Chem Lett (1999) 1.30
Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry. J Virol (1999) 1.29
Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like proteins. Virology (1991) 1.29
Sequence conservation and region shuffling in an endoglucanase and an exoglucanase from Cellulomonas fimi. Proteins (1986) 1.29
Structure of bluetongue virus particles by cryoelectron microscopy. J Struct Biol (1993) 1.29
Bluetongue virus tubules made in insect cells by recombinant baculoviruses: expression of the NS1 gene of bluetongue virus serotype 10. J Virol (1988) 1.27
Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain. J Biol Chem (1998) 1.26
Three-dimensional reconstruction of baculovirus expressed bluetongue virus core-like particles by cryo-electron microscopy. Virology (1992) 1.26
Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. Arch Biochem Biophys (2001) 1.26
Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide. Biochem Pharmacol (2000) 1.24
Synthesis of bluetongue virus-encoded phosphoprotein and formation of inclusion bodies by recombinant baculovirus in insect cells: it binds the single-stranded RNA species. J Gen Virol (1990) 1.24
Bluetongue virus VP6 protein binds ATP and exhibits an RNA-dependent ATPase function and a helicase activity that catalyze the unwinding of double-stranded RNA substrates. J Virol (1997) 1.24
Cyclosporin-A sensitive induction of NF-AT in murine B cells. Immunity (1994) 1.22
A soxA gene, encoding a diheme cytochrome c, and a sox locus, essential for sulfur oxidation in a new sulfur lithotrophic bacterium. J Bacteriol (2000) 1.22
An atomic model of the outer layer of the bluetongue virus core derived from X-ray crystallography and electron cryomicroscopy. Structure (1997) 1.21
Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry (1995) 1.20
Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Am J Ophthalmol (2004) 1.20
Temporally distinct accumulation of transcripts encoding enzymes of the prechorismate pathway in elicitor-treated, cultured tomato cells. Proc Natl Acad Sci U S A (1995) 1.19
Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization. J Virol (2001) 1.19
Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol Pharmacol (1995) 1.18
Production and characterization of the neutralization antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector. Virology (1987) 1.18
The expressed VP4 protein of bluetongue virus binds GTP and is the candidate guanylyl transferase of the virus. Virology (1992) 1.18
[Microscopic hematuria in adults. Prevalence and associated factors]. Presse Med (1991) 1.17
Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol (1993) 1.17
The complete sequence of bluetongue virus serotype 10 segment 3 and its predicted VP3 polypeptide compared with those of BTV serotype 17. Virus Res (1985) 1.16
Purification of the glutamyl-tRNA reductase from Chlamydomonas reinhardtii involved in delta-aminolevulinic acid formation during chlorophyll biosynthesis. J Biol Chem (1990) 1.16
Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability. Br Med J (1975) 1.16